A Dubai court has clarified that neither the insured, the driver responsible for an accident, nor the insured's employees -- if injured during work or as a result of it -- can claim compensation from the insurance company beyond the limit stated in the insurance policy's supplementary endorsement.
The majority (88.3%) of private-sector employees in the UAE have benefited from the unemployment insurance scheme.
China has published its first state-backed catalogue of costly innovative drugs to be covered by private health insurers.
New Zealand general insurer Tower has been ordered to pay a penalty amounting to NZ$7m ($4m) for misleading representations that resulted in more than NZ$11m in overcharges to its customers.
Indonesia is making steady progress toward ensuring everyone can access the health services they need without financial hardship, according to the latest World Health Organization (WHO) and World Bank Group report on universal health coverage (UHC).
The Insurers Federation of Egypt (IFE) has affirmed that adopting AI technologies within the insurance sector is a strategic step toward developing the market, boosting competitiveness, and enhancing operational efficiency across all insurance branches.
AM Best has assigned a Financial Strength Rating of 'B' (Fair) and a Long-Term Issuer Credit Rating of 'bb' (Fair) to Royal Insurance Company (Royal) (Egypt). Additionally, AM Best has assigned the Egypt National Scale Rating of 'aaa.EG' (Exceptional) to Royal. The outlook assigned to these Credit Ratings (ratings) is stable.
The recent overlapping tropical storms and intense monsoon activity in Southeast Asia that began in November 2025 have affected over 11m people, leading to economic losses of over $30bn. The catastrophic events were driven by an unusual convergence of powerful weather systems in the region.
Lloyd's of London has signalled its intentions to enter the International Financial Services Centre (IFSC) GIFT City in India.
Taiwan's National Health Insurance Administration (NHIA) has decided to cover an expensive but effective gene therapy for a rare disease aromatic L-amino acid decarboxylase (AADC) deficiency.